Actively Recruiting
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Led by Neurocrine Biosciences · Updated on 2026-04-15
800
Participants Needed
53
Research Sites
333 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will evaluate the long-term safety of NBI-1117568 in adults with schizophrenia.
CONDITIONS
Official Title
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participant has a primary diagnosis of schizophrenia
- Participants taking prohibited medications, including antipsychotics, must discontinue before study participation
- Participant must reside in a stable housing situation
- Age between 18 and 65 years
You will not qualify if you...
- Participant has known hypersensitivity to any component of the formulation of NBI-1117568
- Participant has an unstable or poorly controlled medical condition or chronic disease
- Participant is considered by the investigator to be at imminent risk of suicide or injury to self or others
- Participant has a diagnosis of moderate or severe substance use disorder (except nicotine or caffeine dependence) within 6 months prior to screening
- Participant has a positive alcohol test or drug screen for disallowed substances
- Participant has a history of poor or suspected poor compliance in clinical research studies or is not capable of following protocol requirements
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 53 locations
1
Neurocrine Clinical Site
Bryant, Arkansas, United States, 72022
Actively Recruiting
2
Neurocrine Clinical Site
Little Rock, Arkansas, United States, 72211
Actively Recruiting
3
Neurocrine Clinical Site
Chino, California, United States, 91710
Actively Recruiting
4
Neurocrine Clinical Site
Culver City, California, United States, 90230
Actively Recruiting
5
Neurocrine Clinical Site
Garden Grove, California, United States, 92845
Actively Recruiting
6
Neurocrine Clinical Site
La Habra, California, United States, 90631
Actively Recruiting
7
Neurocrine Clinical Site
Lemon Grove, California, United States, 91945
Actively Recruiting
8
Neurocrine Clinical Site
Oceanside, California, United States, 92056
Actively Recruiting
9
Neurocrine Clinical Site
Pico Rivera, California, United States, 90660
Actively Recruiting
10
Neurocrine Clinical Site
Riverside, California, United States, 92506
Actively Recruiting
11
Neurocrine Clinical Site
San Diego, California, United States, 92123
Actively Recruiting
12
Neurocrine Clinical Site
Sherman, California, United States, 91403
Actively Recruiting
13
Neurocrine Clinical Site
Torrance, California, United States, 90504
Actively Recruiting
14
Neurocrine Clinical Site
West Hills, California, United States, 91307
Actively Recruiting
15
Neurocrine Clinical Site
Atlantis, Florida, United States, 30328
Actively Recruiting
16
Neurocrine Clinical Site
Aventura, Florida, United States, 33108
Actively Recruiting
17
Neurocrine Clinical Site
Doral, Florida, United States, 33178
Actively Recruiting
18
Neurocrine Clinical Site
Hollywood, Florida, United States, 33024
Actively Recruiting
19
Neurocrine Clinical Site
Maitland, Florida, United States, 32751
Actively Recruiting
20
Neurocrine Clinical Site
Miami, Florida, United States, 33122
Actively Recruiting
21
Neurocrine Clinical Site
Miami Lakes, Florida, United States, 33016
Actively Recruiting
22
Neurocrine Clinical Site
Tampa, Florida, United States, 33629
Actively Recruiting
23
Neurocrine Clinical Site
West Palm Beach, Florida, United States, 33407
Actively Recruiting
24
Neurocrine Clinical Site
Atlanta, Georgia, United States, 30328
Actively Recruiting
25
Neurocrine Clinical Site
Atlanta, Georgia, United States, 30331
Actively Recruiting
26
Neurocrine Clinical Site
Decatur, Georgia, United States, 30030
Actively Recruiting
27
Neurocrine Clinical Sites
Peachtree Corners, Georgia, United States, 30071
Actively Recruiting
28
Neurocrine Clinical Site
Chicago, Illinois, United States, 60640
Actively Recruiting
29
Neurocrine Clinical Site
Gaithersburg, Maryland, United States, 20877
Actively Recruiting
30
Neurocrine Clinical Site
Boston, Massachusetts, United States, 02116
Actively Recruiting
31
Neurocrine Clinical Site
Watertown, Massachusetts, United States, 02472
Actively Recruiting
32
Neurocrine Clinical Site
Flowood, Mississippi, United States, 39232
Actively Recruiting
33
Neurocrine Clinical Site
St Louis, Missouri, United States, 63141
Actively Recruiting
34
Neurocrine Clinical Site
Marlton, New Jersey, United States, 08053
Actively Recruiting
35
Neurocrine Clinical Site
Cedarhurst, New York, United States, 11516
Actively Recruiting
36
Neurocrine Clinical Site
New York, New York, United States, 10029
Actively Recruiting
37
Neurocrine Clinical Site
New York, New York, United States, 10036
Actively Recruiting
38
Neurocrine Clincial Site
Staten Island, New York, United States, 10314
Actively Recruiting
39
Neurocrine Clinical Sites
The Bronx, New York, United States, 10461
Actively Recruiting
40
Neurocrine Clinical Sites
North Canton, Ohio, United States, 44720
Actively Recruiting
41
Neurocrine Clinical Site
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
42
Neurocrine Clinical Site
Austin, Texas, United States, 78754
Actively Recruiting
43
Neurocrine Clinical Site
DeSoto, Texas, United States, 75115
Actively Recruiting
44
Neurocrine Clinical Site
Houston, Texas, United States, 77043
Actively Recruiting
45
Neurocrine Clinical Sites
Orem, Utah, United States, 84058
Actively Recruiting
46
Neurocrine Clinical Site
Orem, Utah, United States, 84058
Actively Recruiting
47
Neurocrine Clinical Site
Bellevue, Washington, United States, 98007
Actively Recruiting
48
Neurocrine Clinical Site
Veliko Tarnovo, Bulgaria, 5047
Withdrawn
49
Neurocrine Clinical Site
Vratsa, Bulgaria, 5047
Actively Recruiting
50
Neurocrine Clinical Site
Brasov, Romania, 500123
Actively Recruiting
51
Neurocrine Clinical Site
Bucharest, Romania, 41914
Actively Recruiting
52
Neurocrine Clinical Site
Sânpetru, Romania, 507190
Actively Recruiting
53
Neurocrine Clinical Site
Belgrade, Serbia, 11000
Actively Recruiting
Research Team
N
Neurocrine Medical Information Call Center
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here